Table 7 The clinicopathologic characteristics of normal control and ovarian cancer patients
Case No. | Age | Histological subtype | Pathological grade | FIGO stage | Tumor location |
|---|---|---|---|---|---|
N1 | 46 | / | / | / | / |
N2 | 53 | / | / | / | / |
N3 | 47 | / | / | / | / |
N4 | 50 | / | / | / | / |
N5 | 53 | / | / | / | / |
N6 | 49 | / | / | / | / |
N7 | 59 | / | / | / | / |
N8 | 48 | / | / | / | / |
N9 | 52 | / | / | / | / |
N10 | 49 | / | / | / | / |
P1 | 46 | serous | G1-G2 | II | bilateral |
P2 | 30 | serous | G1-G2 | III | left |
P3 | 34 | serous | G1-G2 | I | left |
P4 | 55 | serous | G1-G2 | I | bilateral |
P5 | 72 | serous | G1-G2 | III | left |
P6 | 24 | serous | G1-G2 | I | right |
P7 | 72 | serous | G1-G2 | III | left |
P8 | 45 | serous | G1-G2 | III | bilateral |
P9 | 28 | serous | G1-G2 | III | bilateral |
P10 | 26 | serous | G1-G2 | II | bilateral |
P11 | 44 | serous | G3 | III | bilateral |
P12 | 54 | serous | G3 | III | right |
P13 | 47 | serous | G3 | III | bilateral |
P14 | 60 | serous | G3 | III | bilateral |
P15 | 52 | serous | G3 | III | bilateral |
P16 | 44 | serous | G3 | IV | left |
P17 | 50 | serous | G3 | III | bilateral |
P18 | 54 | serous | G3 | III | bilateral |
P19 | 48 | serous | G3 | III | bilateral |
P20 | 60 | serous | G3 | III | bilateral |